14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
WOK vs GCL: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, GCL Global Holdings Ltd (GCL) is the stronger overall head-to-head candidate over WORK Medical Technology Group LTD Class A (WOK) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). WOK carries a Unified Composite Score of 25.6/100 (SELL) at $1.23 (N/M Forward P/E, -41.7% operating margin), whereas GCL carries 31.6/100 (SELL) at $1.16 (N/M Forward P/E, -5.5% operating margin).
Defensive Composite Rating Caution: Although GCL compares more favorably head-to-head, both WOK (25.6/100 SELL) and GCL (31.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on WOK vs GCL. Trailing 12-month operating profitability (WOK -41.7% vs GCL -5.5%) and valuation multiples (WOK N/M vs GCL N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Electronic Gaming & Multimedia value chain with $153.0M market capitalization and -5.5% operating margin.
OpEx & R&D Reinvestment15.8% of Rev ($38M)
90D Engineering Disclosures0 Published
Investor FAQ WOK vs GCL Key Questions & Quantitative Answers
As of Nov 16, 2026, GCL Global Holdings Ltd (GCL) is the stronger overall head-to-head candidate over WORK Medical Technology Group LTD Class A (WOK) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). WOK carries a Unified Composite Score of 25.6/100 (SELL) at $1.23 (N/M Forward P/E, -41.7% operating margin), whereas GCL carries 31.6/100 (SELL) at $1.16 (N/M Forward P/E, -5.5% operating margin). Defensive Composite Rating Caution: Although GCL compares more favorably head-to-head, both WOK (25.6/100 SELL) and GCL (31.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
GCL leads the Growth & Scale pillar: WOK posts +19.1% YoY revenue growth and -95.0% YoY earnings growth on $11M TTM revenue (17.0% gross margin, -41.7% operating margin), compared with GCL at +53.8% YoY revenue growth and N/A YoY earnings growth on $239M TTM revenue (10.3% gross margin, -5.5% operating margin). On trailing 12-month operating scale, WOK generates $11M in USD-normalized revenue versus $239M for GCL. In operating R&D and SG&A reinvestment, WOK deploys 58.7% of Rev ($6.3M) (0 90-day corporate R&D disclosures) versus 15.8% of Rev ($38M) (0 disclosures) for GCL.
WOK and GCL trade at balanced relative valuation multiples. WOK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.5x EV/Revenue (-31.4% EBITDA margin), whereas GCL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.6x EV/Revenue (-4.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WOK (-19.2% ROE) versus GCL (-67.3% ROE) capital efficiency.
In options market volatility and institutional positioning, WOK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (38.49β · 153% Vol realized risk). By comparison, GCL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.52β · 75% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.